Corium to Present at Dawson James Securities Growth Stock Conference
MENLO PARK, Calif. , Oct. 13, 2016 (GLOBE NEWSWIRE) — Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Robert Breuil , Corium’s Chief…